🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. mycophenolate mofetil (CellCept)

    Hoffmann-La Roche

    Myasthenia Gravis, Generalized

    phase 3 small molecule completed

    1 trial

  2. nalbuphine HCl ER

    Trevi Therapeutics

    Uremic Pruritus

    phase 3 small molecule completed

    2 trials

  3. nalbuphine HCl ER

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  4. nalbuphine HCl ER tablets 60 mg BID

    Trevi Therapeutics

    Uremic Pruritus

    phase 3 small molecule completed

    1 trial

  5. nalbuphine HCl ER tablets 90 mg BID

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  6. neoadjuvant chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Ovarian Cancer

    phase 3 small molecule active

    1 trial

  7. neratinib

    PUMA BIOTECHNOLOGY, INC.

    HER2+ Metastatic Breast Cancer (MBC)

    phase 3 small molecule completed

    1 trial

  8. nexiguran ziclumeran

    Regeneron UK Limited

    Neuromuscular Disease

    phase 3 mab active

    1 trial

  9. nomacopan (rVA576)

    Akari Therapeutics Plc

    Bullous Pemphigoid

    phase 3 small molecule terminated

    1 trial

  10. nomacopan (rVA576)

    Akari Therapeutics Plc

    Thrombotic Microangiopathies

    phase 3 small molecule terminated

    1 trial

  11. ofloxacin

    ABEONA THERAPEUTICS INC.

    Diabetic Foot Ulcers

    phase 3 small molecule completed

    2 trials

  12. oral estradiol 1.0 mg

    TherapeuticsMD

    Menopause

    phase 3 small molecule completed

    1 trial

  13. paclitaxel

    United Therapeutics Europe Ltd

    Germ Cell Tumor

    phase 3 small molecule active

    1 trial

  14. pad-gauze with tranexamic acid (Hemostopan™)

    Sionna Therapeutics

    Bleeding

    phase 3 other active

    1 trial

  15. pegaptanib sodium

    Pfizer

    Macular Degeneration

    phase 3 small molecule completed

    1 trial

  16. pegfilgrastim

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 mab active

    1 trial

  17. perampanel

    Eisai Co.,

    Epilepsy

    phase 3 small molecule completed

    2 trials

  18. postoperative antimicrobial prophylaxis

    Sun Yat-sen University

    Hepatocellular Carcinoma

    phase 3 small molecule on hold

    1 trial

  19. pralatrexate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Peripheral T-Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  20. preoperative short-course radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Neoplasms

    phase 3 other terminated

    1 trial

  21. probiotic strain Bb-12

    United Therapeutics Europe Ltd

    Infections, Respiratory

    phase 3 other completed

    1 trial

  22. rVA576

    Akari Therapeutics Plc

    Paroxysmal Nocturnal Hemoglobinuria

    phase 3 small molecule terminated

    1 trial

  23. rVA576

    Akari Therapeutics Plc

    Paroxysmal Nocturnal Hemoglobinuria (PNH)

    phase 3 small molecule completed

    1 trial

  24. radiation therapy

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources